• Strategy
  • Portfolio
  • People
  • Careers
  • News
  • Blog
  • Contact Us
Foresite News
Press Releases
Portfolio News

For press inquiries click here to contact us.

The Boston Globe

Boston Biotech Intarcia Raises Major Funding for Type 2 Diabetes Treatment

September 15, 2016
GenomeWeb

10X Genomics Inks Japanese Distribution Deal

September 15, 2016
Yahoo Finance

Orexigen Therapeutics Announces Commercialization And Distributorship Agreement With Valeant Canada

August 30, 2016
FierceBiotech

Stealthy Arcus Emerges With $120M To Make Personalized I/O Therapy A Reality

August 29, 2016
Yahoo Finance

Aimmune Therapeutics To Announce Phase 2 Data At EAACI Congress 2015 For Study Of Peanut Allergy Desensitization Treatment

June 13, 2016
GenomeWeb

10X Genomics Signs Asia-Pacific Distribution Deals

May 11, 2016
FierceBiotech

Pfizer Inks A $911M Discovery Pact With Greg Verdine’s WaVe Life Sciences

May 5, 2016
TheStreet

Acceleron, Celgene Seek to Replace Entrenched Anti-Anemia Drugs in MDS Treatment

April 16, 2016
FierceBiotech

10X Genomics Scoops Another $55M To Fuel Commercialization Of Long-Read Tech

March 21, 2016
FierceBiotech

Aimmune’s Peanut Allergy Drug Clears Phase II On The Way To A Pivotal Test

March 7, 2016
Page 22 of 25« First«...10...2021222324...»Last »

Please see important disclaimers in the Terms section.


©2022 Foresite Capital Management, LLC. Site by GOODLAB

    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
    Close
    • News
    • Blog
    • Foresite Labs
    • Contact Us
    • Home
    • Strategy
    • Portfolio
    • People
    • Careers
    • News
    • Blog
    • Contact Us
    • Foresite Labs
    • Investor Login
    • Terms
    • Privacy Policy
      • Blog
      • Careers
      • Contact Us
      • Disclosures
      • Home
      • Legal Disclaimers
      • Pardes Biosciences Legend
      • Privacy Policy
      • Strategy
      • Terms

    ©2025 Foresite Capital Management, LLC.

    Site by Goodlab

    Close